All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0722-YF4 | TS-Fluc Anti-Human CA9 scFv (CB515) CD28-CD3ζ CAR, pCDCAR1 | Human | CB515 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF184 | TS-IL15 SA Anti-Human CA9 scFv (CB515) CD28-CD3ζ CAR, pCDCAR1 | Human | CB515 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF244 | TS-IL15 SA Anti-Human CA9 scFv (CB515) 4-1BB-CD3ζ CAR, pCDCAR1 | Human | CB515 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF304 | TS-IL15 SA Anti-Human CA9 scFv (CB515) CD28-4-1BB-CD3ζ CAR, pCDCAR1 | Human | CB515 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX1 | Anti-CA9 (X9X1) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX2 | Anti-CA9 (X9X2) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX399 | Anti-CA9 (X9X1) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX400 | Anti-CA9 (X9X2) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-LX598 | Anti-CA9 (X9X1) Negative Control CAR, pCDCAR1 | Human | X9X1 | Mouse | scFv-CD28/CD8TM | Lentiviral vector | T cell | ||
XS-0922-LX599 | Anti-CA9 (X9X2) Negative Control CAR, pCDCAR1 | Human | X9X2 | Mouse | scFv-CD28/CD8TM | Lentiviral vector | T cell | ||
XS-1122-YF7403 | Anti-CA9 (CB515) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | CB515 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP273 | Anti-CA9 (G250) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | G250 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP274 | Anti-CA9 (Girentuximab) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Girentuximab | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP275 | Anti-CA9 (G37) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | G37 | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP525 | Anti-CA9 (MSC3) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | MSC3 | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP273 | Anti-CA9 (G250 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | G250 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP274 | Anti-CA9 (Girentuximab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Girentuximab | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP275 | Anti-CA9 (G37 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | G37 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP525 | Anti-CA9 (MSC3 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | MSC3 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0823-LX3 | Anti-hCA9 (H1L1) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | H1L1 | Adenoviral vectors | |||||
XS-0923-LX36 | Anti-hCA9 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-5 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION